Charles River Laboratories International, Inc.
NYSE · Healthcare · Services-Commercial Physical & Biological Research · Wilmington, MA
CRL chart
What traders are saying about $CRL
Latest postsCharles River Laboratories International, Inc. news
- Charles River Laboratories Recent $470 Million Deal an 'Attractive Strategic Addition,' Analyst Says
Yahoo Finance ·
- Charles River agrees $470m deal for Frontage assets
hospitalmanagement.net ·
- Tigermed to Participate in the Privatization of Frontage Holdings Corporation and Divest Its Overseas Laboratory Services Business
Yahoo Finance ·
- Overseas lab services may be sold as Tigermed keeps Frontage's China business
Stock Titan ·
- 649 shares cover vesting taxes for Charles River (CRL) finance executive Michael Gunnar Knell.
Stock Titan ·
- Form 8K Charles River Laboratories International, Inc For: 9 November By Investing.com
Investing.com Nigeria ·
- Charles River Laboratories International - De
Moomoo ·
- Unlocking Charles River (CRL) International Revenues: Trends, Surprises, and Prospects
Yahoo Finance ·
- CRAI Q3 Earnings & Revenues Surpass Estimates, Stock Barely Moves
Yahoo Finance ·
- Is Charles River Laboratories International (CRL) Fully Valued After Raised EPS Guidance?
Simply Wall St ·
- Charles River Laboratories to Acquire Frontage’s Bioanalysis and DMPK Businesses
Yahoo Finance ·
- Dimensional U.S. Small Cap ETF (DFAS) Sells $24.2 Million of Charles River on Nov. 5
Yahoo Finance ·
Charles River Laboratories International, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $4.02B | $4.05B | $4.13B | $3.98B |
| Net income | -$144.3M | $22.2M | $474.6M | $486.2M |
| Diluted EPS | $-2.91 | $0.20 | $9.22 | $9.48 |
| Total assets (year end) | $7.14B | $7.53B | $8.20B | $7.60B |
| Cash and equivalents (year end) | $213.8M | $194.6M | $276.8M | $233.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Charles River Laboratories International, Inc.
- Ticker
- CRL (NYSE)
- Industry
- Services-Commercial Physical & Biological Research
- Headquarters
- Wilmington, MA
- Fiscal year end
- December 27
- SEC CIK
- 1100682
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
Frequently asked questions
What exchange is Charles River Laboratories International, Inc. listed on?
Charles River Laboratories International, Inc. trades on the NYSE under the ticker symbol CRL.
What industry is Charles River Laboratories International, Inc. in?
Charles River Laboratories International, Inc. is classified by the SEC under "Services-Commercial Physical & Biological Research", part of the Healthcare sector on StockTweeting.
Where is Charles River Laboratories International, Inc. headquartered?
Charles River Laboratories International, Inc.'s business address on file with the SEC is in Wilmington, MA.
When does Charles River Laboratories International, Inc.'s fiscal year end?
Charles River Laboratories International, Inc.'s fiscal year ends on December 27.
How much revenue did Charles River Laboratories International, Inc. report?
Charles River Laboratories International, Inc. reported $4.02B in revenue for calendar year 2025, according to its SEC filings.